Abstract:ABSTRACT Candida albicans is a prevalent opportunistic pathogenic fungus that resides in the skin and gastrointestinal (GI) tract of humans. Under specific conditions, C. albicans cells transition from a commensal to a pathogenic state, leading to both superficial and invasive infections. Although systemic candidiasis poses a life-threatening risk, a limited number of antifungal drugs are employed for its treatment. Moreover, the emergence of resistant strains to antifungal agents underscores the pressing need for new treatment options. In this study, we propose the use of polysaccharide nanoparticles as a strategy for treating candidiasis. We synthesized phthalic pullulan nanoparticles (PPNPs) and examined their ability to inhibit the pathogenicity of C. albicans . We observed that PPNPs inhibit hyphal growth, adhesion to abiotic surfaces, and biofilm formation of C. albicans in a dose-dependent manner. This inhibitory effect is mediated by transcriptional modulation, particularly the downregulation of hypha-related genes and the upregulation of stress-responsive genes, involving the Ras/cAMP/PKA signaling pathway. Furthermore, we observed that PPNPs inhibit the adhesion of C. albicans to human epithelial cells without inducing toxicity in human cells. In addition, PPNPs inhibited the in vivo pathogenicity of C. albicans in Caenorhabditis elegans , suggesting an antagonistic effect on candidiasis. Our findings suggest that PPNPs exhibit inhibitory effects on C. albicans biofilm formation and in vivo pathogenicity, indicating their potential as a novel therapeutic agent for candidiasis. IMPORTANCE The pathogenic process of Candida albicans , the primary causative species of candidiasis, involves hyphal growth, biofilm formation, and secretion of virulence factors. Of these factors, the biofilm, created by the secretion of extracellular matrix from adherent cells, shields cells from external threats, enabling them to withstand high concentrations of antifungal agents. Therefore, suppressing biofilm formation is a crucial aspect of combating candidiasis. This study developed phthalic pullulan nanoparticles (PPNPs) as a novel material for inhibiting C. albicans ’ pathogenicity. PPNPs were internalized within Candida cells and reduced pathogenicity at the gene expression level, resulting in reduced in vitro biofilm formation, adhesion to human cells, and mortality of infected Caenorhabditis elegans . Moreover, PPNPs exhibited these effects without toxicity to human cells and host animals. These findings not only indicate that PPNPs can be employed to hinder in vitro biofilm formation but also suggest their potential as a novel treatment for candidiasis.

Phospholipid/protein co-mediated assembly of Cu2O nanoparticles for specific inhibition of growth and biofilm formation of pathogenic fungi

Fungus-mediated Biosynthesis of Gold Nanoparticles with Synergistic Antifungal Activity Against Multidrug-Resistant Candida Albicans

Nanoparticle-Based Photodynamic Inhibition of Candida Albicans Biofilms with Interfering Quorum Sensing

Inhibition of gold nanoparticles (AuNPs) on pathogenic biofilm formation and invasion to host cells

Mucus-Permeable Sonodynamic Therapy Mediated Amphotericin B-Loaded PEGylated PLGA Nanoparticles Enable Eradication of Candida albicans Biofilm

Synergistic wall digestion and cuproptosis against fungal infections using lywallzyme-induced self-assembly of metal-phenolic nanoflowers

The enhancing antifungal effect of AD1 aptamer-functionalized amphotericin B-loaded PLGA-PEG nanoparticles with a low-frequency and low-intensity ultrasound exposure on C.albicans biofilm through targeted effect

Pullulan nanoparticles inhibit the pathogenicity of Candida albicans by regulating hypha-related gene expression

Nanoparticles Targeted Against Cryptococcal Pneumonia by Interactions Between Chitosan and Its Peptide Ligand

A Self-Assembling Peptide Inhibits the Growth and Function of Fungi Via a Wrapping Strategy

High inhabitation activity of CMCS/Phytic acid/Zn 2+ nanoparticles via flash nanoprecipitation (FNP) for bacterial and fungal infections

Cu-based Nanozymes Effectively Inhibit Proliferation of Fungal Pathogens by Catalyzing ROS Yield

Supramolecular Assemblies of Heterogeneous Mesoporous Silica Nanoparticles to Co-Deliver Antimicrobial Peptides and Antibiotics for Synergistic Eradication of Pathogenic Biofilms.

Biomimetic and multifunctional nanocomposites for precision fungi theranostics

Photosensitizer‐Polypeptide Conjugate for Effective Elimination of Candida albicans Biofilm

Bioresponsive micro-to-nano albumin-based systems for targeted drug delivery against complex fungal infections

A Novel Silver Nanoparticles‐Decorated Metal‐Organic Framework with Rapid and Sustained Antimicrobial Activity Against Drug‐Resistant Candida Albicans Through Synergistic Chemodynamic and Sonodynamic Therapy

Bi-functional quercetin/copper nanoparticles integrating bactericidal and anti-quorum sensing properties for preventing the formation of biofilms

Nanoparticles Self-Assembled from Berberine and Chrysin for Generating Antimicrobial Films

Cascade-targeting polymeric particles eliminate intracellular C. neoformans in fungal infection therapy

Antimicrobial Nanostructured Assemblies with Extremely Low Toxicity and Potent Activity to Eradicate Staphylococcus Aureus Biofilms.